TREATswitzerland is the patient registry for atopic dermatitis (neurodermatitis) in Switzerland. To date, there is a lack of accurate data on the medical care of patients with atopic dermatitis, the course of the disease and response to treatment, and the impact on quality of life. In an observational study of patients with moderate and severe atopic dermatitis, data will be collected and scientifically evaluated (observational cohort study).

This objective of the registry study should be reflected in the illustrations. We also want to give the patients a face – to show the burden that atopic dermatitis brings with it, as well as the positive effect of effective therapy.